Aster DM Healthcare has scheduled meetings with analysts and institutional investors on June 3 and June 4, 2026, in Mumbai. The company will participate in the BoFA 2026 India Conference and the Citi India Conference 2026 through its representatives. These interactions are intended to engage with the investor community without disclosing any unpublished price sensitive information.

The meetings will be conducted in-person, featuring both investor group sessions and one-on-one interactions. The schedule for the events is detailed below:

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the schedule is subject to change due to exigencies on the part of investors, analysts, or the company. Hemish Purushottam, Company Secretary and Compliance Officer, signed the intimation on May 25, 2026.

Union Investments Private Limited has submitted a declaration to Aster DM Healthcare Limited's Audit Committee, BSE Limited, and the National Stock Exchange of India Ltd, confirming that no encumbrance of shares has been created during the financial year 2025-2026. The declaration, dated 3rd April 2026, was filed in accordance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Regulatory Declaration Details

The filing confirms that Union Investments Private Limited, together with persons acting in concert, has not made any encumbrance—directly or indirectly—on shares of Aster DM Healthcare Limited, other than those already disclosed, during the financial year 2025-2026. The declaration was signed by Dr. Mandayapurath Azad Moopen, Director of Union Investments Private Limited.

The key details of the filing are summarised below:

Filing Addressed To

The declaration was submitted to the following recipients:

• BSE Limited, Listing Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001
• National Stock Exchange of India Ltd, Listing Department, Bandra Kurla Complex, Bandra (East), Mumbai 400051
• Audit Committee, Aster DM Healthcare Limited, Awfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Sampangi Rama Nagar, Bangalore, Karnataka, India, 560027

Compliance Context

Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 mandates that promoters and persons acting in concert declare, at the end of each financial year, whether any encumbrance has been created on shares held in the target company. This filing by Union Investments Private Limited affirms full compliance with this regulatory requirement for the financial year 2025-2026, with no new or undisclosed encumbrances reported.